Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease:A Randomized, Double-Blind, Placebo-Controlled Study

NCT01879293 is registered in ClinicalTrials.gov with Wuhan General Hospital of Guangzhou Military Command as lead sponsor.

NCT NCT01879293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01879293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease:A Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
Wuhan General Hospital of Guangzhou Military Command
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
August 31, 2015
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventriclar mass